Monthly Archives: March 2022

COVID-19: talk of ‘vaccine hesitancy’ lets governments off the hook

Posted on by

Nature
Volume 602 Issue 7898, 24 February 2022
https://www.nature.com/nature/volumes/602/issues/7898

 

Comment | 22 February 2022
COVID-19: talk of ‘vaccine hesitancy’ lets governments off the hook
Go beyond the attitudes of individuals and focus more on what governments must do to build people’s trust and ensure easy access to vaccines for all.
Katie Attwell, Adam Hannah, Julie Leask

Omicron extensively but incompletely escapes Pfizer BNT162b2 neutralization

Posted on by

Nature
Volume 602 Issue 7898, 24 February 2022
https://www.nature.com/nature/volumes/602/issues/7898

 

Article | 23 December 2021 | Open Access
Omicron extensively but incompletely escapes Pfizer BNT162b2 neutralization
Plasma from individuals vaccinated with BNT162b2 exhibits 22-fold less neutralization capacity against Omicron (B.1.1.529) than against an ancestral SARS-CoV-2 strain but residual neutralization is maintained in those with high levels of neutralization of ancestral virus.
Sandile Cele, Laurelle Jackson, Alex Sigal

Omicron escapes the majority of existing SARS-CoV-2 neutralizing antibodies

Posted on by

Nature
Volume 602 Issue 7898, 24 February 2022
https://www.nature.com/nature/volumes/602/issues/7898

 

Article | 23 December 2021 | Open Access
Omicron escapes the majority of existing SARS-CoV-2 neutralizing antibodies
A high-throughput yeast display platform is used to analyse the profiles of mutations in the SARS-CoV-2 receptor-binding domain (RBD) that enable escape from antibodies, and suggests that most anti-RBD antibodies can be escaped by the Omicron variant.
Yunlong Cao, Jing Wang, Xiaoliang Sunney Xie

Broadly neutralizing antibodies overcome SARS-CoV-2 Omicron antigenic shift

Posted on by

Nature
Volume 602 Issue 7898, 24 February 2022
https://www.nature.com/nature/volumes/602/issues/7898

 

Article | 23 December 2021
Broadly neutralizing antibodies overcome SARS-CoV-2 Omicron antigenic shift
Pseudovirus assays and surface plasmon resonance show that the Omicron receptor-binding domain binds to human ACE2 with increased affinity relative to the ancestral virus, and that most neutralizing antibodies are considerably less potent against Omicron.
Elisabetta Cameroni, John E. Bowen, Davide Corti

Considerable escape of SARS-CoV-2 Omicron to antibody neutralization

Posted on by

Nature
Volume 602 Issue 7898, 24 February 2022
https://www.nature.com/nature/volumes/602/issues/7898

 

Article | 23 December 2021
Considerable escape of SARS-CoV-2 Omicron to antibody neutralization
An isolate of the Omicron variant of SARS-COV-2 was completely or partially resistant to neutralization by all nine clinically approved monoclonal antibodies tested.
Delphine Planas, Nell Saunders, Olivier Schwartz

Striking antibody evasion manifested by the Omicron variant of SARS-CoV-2

Posted on by

Nature
Volume 602 Issue 7898, 24 February 2022
https://www.nature.com/nature/volumes/602/issues/7898

 

Article | 23 December 2021
Striking antibody evasion manifested by the Omicron variant of SARS-CoV-2
The B.1.1.529/Omicron variant of SARS-CoV-2 is resistant to neutralization by serum not only from patients who recovered from COVID-19, but also from individuals vaccinated with one of the four widely used COVID-19 vaccines.
Lihong Liu, Sho Iketani, David D. Ho

Activity of convalescent and vaccine serum against SARS-CoV-2 Omicron

Posted on by

Nature
Volume 602 Issue 7898, 24 February 2022
https://www.nature.com/nature/volumes/602/issues/7898

 

Article | 31 December 2021
Activity of convalescent and vaccine serum against SARS-CoV-2 Omicron
Sera from unvaccinated, vaccinated, and previously infected and vaccinated individuals show reduced neutralizing and spike protein-binding activity towards the Omicron (B.1.1.529) variant of SARS-CoV-2 compared to other variants.
Juan Manuel Carreño, Hala Alshammary, Florian Krammer

Focus on vaccine inequity

Posted on by

Nature Human Behaviour
Volume 6 Issue 2, February 2022
https://www.nature.com/nathumbehav/volumes/6/issues/2

 

Focus on vaccine inequity
Equitable distribution of resources to fight COVID-19 is a global challenge. In a collection of research and opinion articles, researchers, public health officials, intellectual property experts, leaders of international organizations, and activists explain how global inequities in COVID-19 vaccine allocation continue fuelling the pandemic, and discuss ways to address these disparities.

In a pandemic, national and global interests converge

Posted on by

Nature Human Behaviour
Volume 6 Issue 2, February 2022
https://www.nature.com/nathumbehav/volumes/6/issues/2

 

Editorial | 31 January 2022
In a pandemic, national and global interests converge
In ten contributions, mathematical modellers, public health officials, intellectual property experts and activists explain how vaccine inequities continue to fuel the pandemic, and how multilateral cooperation can help.

Vaccine inequity is unethical

Posted on by

Nature Human Behaviour
Volume 6 Issue 2, February 2022
https://www.nature.com/nathumbehav/volumes/6/issues/2

 

World View | 31 January 2022
Vaccine inequity is unethical
Ethical principles dictate that limited, life-saving resources should be allocated fairly. Keymanthri Moodley affirms that achieving global distributive justice is one of the greatest challenges of the COVID-19 pandemic, and current distribution strategies are ethically indefensible.
Keymanthri Moodley

The emergence of COVID-19 vaccine resistance depends on human choices

Posted on by

Nature Human Behaviour
Volume 6 Issue 2, February 2022
https://www.nature.com/nathumbehav/volumes/6/issues/2

 

Research Briefing | 24 February 2022
The emergence of COVID-19 vaccine resistance depends on human choices
The probability of the emergence of SARS-CoV-2 vaccine-resistant variants depends on the number of daily infections permitted by society, and the rate and penetrance of vaccination. Rapidly vaccinating all eligible people while maintaining strict physical distancing measures can prevent the evolution of vaccine resistance.

Equitable access to COVID-19 vaccines makes a life-saving difference to all countries

Posted on by

Nature Human Behaviour
Volume 6 Issue 2, February 2022
https://www.nature.com/nathumbehav/volumes/6/issues/2

 

Article | 31 January 2022 | Open Access
Equitable access to COVID-19 vaccines makes a life-saving difference to all countries
Using data-driven mathematical modelling that combines viral evolution with epidemiological dynamics, Ye et al. show that COVID-19 vaccine inequity leads to the emergence of new variants and new waves of the pandemic, while equitable allocation of vaccine doses reduces case counts and fatalities in all countries.
Yang Ye, Qingpeng Zhang, Daniel Dajun Zeng

The French health pass holds lessons for mandatory COVID-19 vaccination

Posted on by

Nature Medicine
Volume 28 Issue 2, February 2022
https://www.nature.com/nm/volumes/28/issues/2

 

Comment | 12 January 2022
The French health pass holds lessons for mandatory COVID-19 vaccination
The passe sanitaire increased levels of vaccination, but to a lower extent among the most vulnerable, and did not reduce vaccine hesitancy itself, showing the importance of outreach to underserved communities and the potential limits of mandatory vaccination policies.
Jeremy K. Ward, Fatima Gauna, Patrick Peretti-Watel

A roadmap to increase diversity in genomic studies

Posted on by

Nature Medicine
Volume 28 Issue 2, February 2022
https://www.nature.com/nm/volumes/28/issues/2

 

Perspective | 10 February 2022
A roadmap to increase diversity in genomic studies
Based on their experience of setting up genomic studies in underrepresented populations, the authors propose a roadmap to enhancing inclusion and ensuring that the health benefits of genomics advances are accessible to all.
Segun Fatumo, Tinashe Chikowore, Karoline Kuchenbaecker

Influenza virus infection history shapes antibody responses to influenza vaccination

Posted on by

Nature Medicine
Volume 28 Issue 2, February 2022
https://www.nature.com/nm/volumes/28/issues/2

 

Article | 17 February 2022
Influenza virus infection history shapes antibody responses to influenza vaccination
Recent prior influenza A infection is associated with elevated hemagglutinin-inhibiting antibody responses and greater breadth of reactivity to influenza strains following vaccination, suggesting that infection history boosts vaccine responses.
Maria Auladell, Hoang Vu Mai Phuong, Annette Fox

Risks of myocarditis, pericarditis, and cardiac arrhythmias associated with COVID-19 vaccination or SARS-CoV-2 infection

Posted on by

Nature Medicine
Volume 28 Issue 2, February 2022
https://www.nature.com/nm/volumes/28/issues/2

 

Article | 14 December 2021 | Open Access
Risks of myocarditis, pericarditis, and cardiac arrhythmias associated with COVID-19 vaccination or SARS-CoV-2 infection
A self-controlled case series using individual-patient-level data from over 38 million people aged 16 years and over, reveals an increased risk of myocarditis within a week of receiving a first dose of ChAdOx1, BNT162b2 and mRNA-1273 vaccines, which was further increased after a second dose of either mRNA vaccine. SARS-CoV-2 infection was associated with even greater risk of myocarditis, as well as pericarditis and cardiac arrhythmia.
Martina Patone, Xue W. Mei, Julia Hippisley-Cox

First dose ChAdOx1 and BNT162b2 COVID-19 vaccinations and cerebral venous sinus thrombosis: A pooled self-controlled case series study of 11.6 million individuals in England, Scotland, and Wales

Posted on by

PLoS Medicine
http://www.plosmedicine.org/
(Accessed 26 Feb 2022)

 

First dose ChAdOx1 and BNT162b2 COVID-19 vaccinations and cerebral venous sinus thrombosis: A pooled self-controlled case series study of 11.6 million individuals in England, Scotland, and Wales
Steven Kerr, Mark Joy, Fatemeh Torabi, Stuart Bedston, Ashley Akbari, Utkarsh Agrawal, Jillian Beggs, Declan Bradley, Antony Chuter, Annemarie B. Docherty, David Ford, Richard Hobbs, Srinivasa Vittal Katikireddi, Emily Lowthian, Simon de Lusignan, Ronan Lyons, James Marple, Colin McCowan, Dylan McGagh, Jim McMenamin, Emily Moore, Josephine-L. K. Murray, Rhiannon K. Owen, Jiafeng Pan, Lewis Ritchie, Syed Ahmar Shah, Ting Shi, Sarah Stock, Ruby S. M. Tsang, Eleftheria Vasileiou, Mark Woolhouse, Colin R. Simpson, Chris Robertson, Aziz Sheikh
Research Article | published 22 Feb 2022 PLOS Medicine
https://doi.org/10.1371/journal.pmed.1003927

Uptake of infant and preschool immunisations in Scotland and England during the COVID-19 pandemic: An observational study of routinely collected data

Posted on by

PLoS Medicine
http://www.plosmedicine.org/
(Accessed 26 Feb 2022)

 

Uptake of infant and preschool immunisations in Scotland and England during the COVID-19 pandemic: An observational study of routinely collected data
Fiona McQuaid, Rachel Mulholland, Yuma Sangpang Rai, Utkarsh Agrawal, Helen Bedford, J. Claire Cameron, Cheryl Gibbons, Partho Roy, Aziz Sheikh, Ting Shi, Colin R. Simpson, Judith Tait, Elise Tessier, Steve Turner, Jaime Villacampa Ortega, Joanne White, Rachael Wood
Research Article | published 22 Feb 2022 PLOS Medicine
https://doi.org/10.1371/journal.pmed.1003916

Measles containing vaccine coverage and factors associated with its uptake among children aged 24–59 months in Cherangany Sub County, Trans Nzoia County, Kenya

Posted on by

PLoS One
http://www.plosone.org/
[Accessed 26 Feb 2022]

 

Measles containing vaccine coverage and factors associated with its uptake among children aged 24–59 months in Cherangany Sub County, Trans Nzoia County, Kenya
Stella Mamuti, Collins Tabu, Irene Marete, Davies Opili, Rose Jalang’o, Ahmed Abade
Research Article | published 23 Feb 2022 PLOS ONE
https://doi.org/10.1371/journal.pone.0263780

Determinants of acceptance of Coronavirus disease-2019 (COVID-19) vaccine among Lebanese health care workers using health belief model

Posted on by

PLoS One
http://www.plosone.org/
[Accessed 26 Feb 2022]

 

Determinants of acceptance of Coronavirus disease-2019 (COVID-19) vaccine among Lebanese health care workers using health belief model
Dalal Youssef, Linda Abou-Abbas, Atika Berry, Janet Youssef, Hamad Hassan
Research Article | published 22 Feb 2022 PLOS ONE
https://doi.org/10.1371/journal.pone.0264128

Media attention and Vaccine Hesitancy: Examining the mediating effects of Fear of COVID-19 and the moderating role of Trust in leadership

Posted on by

PLoS One
http://www.plosone.org/
[Accessed 26 Feb 2022]

 

Media attention and Vaccine Hesitancy: Examining the mediating effects of Fear of COVID-19 and the moderating role of Trust in leadership
Lulin Zhou, Sabina Ampon-Wireko, Xinglong Xu, Prince Edwudzie Quansah, Ebenezer Larnyo
Research Article | published 18 Feb 2022 PLOS ONE
https://doi.org/10.1371/journal.pone.0263610

Understanding the Facilitators and Barriers to COVID-19 Vaccine Uptake Among Teachers in the Sagnarigu Municipality of Northern Ghana: A Cross-Sectional Study

Posted on by

Risk Management and Healthcare Policy
https://www.dovepress.com/risk-management-and-healthcare-policy-archive56
[Accessed 26 Feb 2022]

 

Original Research
Understanding the Facilitators and Barriers to COVID-19 Vaccine Uptake Among Teachers in the Sagnarigu Municipality of Northern Ghana: A Cross-Sectional Study
Dubik SD
Published Date: 24 February 2022

Predicting the mutational drivers of future SARS-CoV-2 variants of concern

Posted on by

Science Translational Medicine
Volume 14| Issue 633| 23 Feb 2022
https://www.science.org/toc/stm/current

 

Research Articles
Predicting the mutational drivers of future SARS-CoV-2 variants of concern
BY M. Cyrus Maher, et al.
23 Feb 2022
Open Access
Simple epidemiologic metrics accurately predict which mutations in the SARS-CoV-2 genome will increase in frequency over the coming months.

COVID-19 and Routine Childhood and Adolescent Immunizations: Evidence from Louisiana Medicaid

Posted on by

Vaccine
Volume 40, Issue 6 Pages 833-966 (7 February 2022)
https://www.sciencedirect.com/journal/vaccine/vol/40/issue/6

 

Short communication Full text access
COVID-19 and Routine Childhood and Adolescent Immunizations: Evidence from Louisiana Medicaid
Brigham Walker, Andrew Anderson, Charles Stoecker, Yixue Shao, … Kevin Callison
Pages 837-840

Improving knowledge and trust in vaccines: A survey-based assessment of the potential of the European Union Clinical Trial Regulation No 536/2014 plain language summary to increase health literacy

Posted on by

Vaccine
Volume 40, Issue 6 Pages 833-966 (7 February 2022)
https://www.sciencedirect.com/journal/vaccine/vol/40/issue/6

 

Research article Open access
Improving knowledge and trust in vaccines: A survey-based assessment of the potential of the European Union Clinical Trial Regulation No 536/2014 plain language summary to increase health literacy
Michael Penlington, Philibert Goulet, Beth Metcalfe
Pages 924-933

COVID-19 and missed or delayed vaccination in 26 middle- and high-income countries: An observational survey

Posted on by

Vaccine
Volume 40, Issue 6 Pages 833-966 (7 February 2022)
https://www.sciencedirect.com/journal/vaccine/vol/40/issue/6

 

Research article Open access
COVID-19 and missed or delayed vaccination in 26 middle- and high-income countries: An observational survey
Gilla K. Shapiro, Nisha Gottfredson, Julie Leask, Kerrie Wiley, … Noel T. Brewer
Pages 945-952

Pre-Print Servers

Posted on by

Pre-Print Servers

 

Gates Open Research
https://gatesopenresearch.org/browse/articles
[Accessed 26 Feb 2022]

Research Article metrics
Revised
Do differentiated service delivery models for HIV treatment in sub-Saharan Africa save money? Synthesis of evidence from field studies conducted in sub-Saharan Africa in 2017-2019 [version 2; peer review: 1 approved, 1 approved with reservations]
Sydney Rosen, Brooke Nichols, Teresa Guthrie, Mariet Benade, Salome Kuchukhidze, Lawrence Long
Peer Reviewers Ingrid Eshun-Wilson; Michael J. Vinikoor
Funder
NIH
LATEST VERSION PUBLISHED 25 Feb 2022

 

medRxiv
https://www.medrxiv.org/content/about-medrxiv
medRxiv is a free online archive and distribution server for complete but unpublished manuscripts (preprints) in the medical, clinical, and related health sciences. Preprints are preliminary reports of work that have not been certified by peer review. They should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information. medRxiv is for the distribution of preprints – complete but unpublished manuscripts – that describe human health research conducted, analyzed, and interpreted according to scientific principles…

Waning Effectiveness of the Third Dose of the BNT162b2 mRNA COVID-19 Vaccine
Tal Patalon, Yaki Saciuk, Asaf Peretz, Galit Perez, Yoav Lurie, Yasmin Maor, Sivan Gazit
medRxiv 2022.02.25.22271494; doi: https://doi.org/10.1101/2022.02.25.22271494

The effect of job strain and worksite social support on reported side effects of COVID-19 vaccine: a prospective study of employees in Japan
Natsu Sasaki, Reiko Kuroda, Kanami Tsuno, Kotaro Imamura, Norito Kawakami
medRxiv 2022.02.24.22271484; doi: https://doi.org/10.1101/2022.02.24.22271484

Booster protection against Omicron infection in a highly vaccinated cohort
Caroline Tai, Lisa L Maragakis, Sarah Connelly, John DiFiori, Leroy Sims, Eleanor Adams, Deverick Anderson, Michael Merson, David Ho, Yonatan Grad, Christina DeFilippo Mack
medRxiv 2022.02.24.22271347; doi: https://doi.org/10.1101/2022.02.24.22271347

Rapid genome surveillance of SARS-CoV-2 and study of risk factors using shipping container laboratories and portable DNA sequencing technology
SARA FARAHI BILOOEI, Dejana Jovicevic, Arash Iranzadeh, Cynthia Mpofu, Ivan Muscat, Anthony Thomas, Helene Steiner, Thomas Meany
medRxiv 2022.02.25.22271277; doi: https://doi.org/10.1101/2022.02.25.22271277

Public Health Impact of the Pfizer-BioNTech COVID-19 vaccine (BNT162b2) in the first year of rollout in the United States
Manuela Di Fusco, Kinga Marczell, Kristen A Deger, Mary M Moran, Timothy L Wiemken, Alejandro Cane, Solene de Boisvilliers, Jingyan Yang, Shailja Vaghela, Julie Roiz
medRxiv 2022.02.24.22271478; doi: https://doi.org/10.1101/2022.02.24.22271478

At least three doses of leading vaccines essential for neutralisation of SARS-CoV-2 Omicron variant
Nagendrakumar B Singanallur, Petrus Jansen van Vuren, Alexander James McAuley, Matthew P Bruce, Michael J Kuiper, Stella May Gwini, Shane Riddell, Sarah Goldie, Trevor W Drew, Kim Rebecca Blasdell, Mary Tachedjian, Shruthi Mangalaganesh, Simran Chahal, Leon Caly, Julian D Druce, Jennifer A Juno, Stephen Kent, Adam K Wheatley, Seshadri S Vasan
medRxiv 2022.02.20.22271237; doi: https://doi.org/10.1101/2022.02.20.22271237

Effectiveness of the third dose of BNT162b2 vaccine on neutralizing Omicron variant in the Japanese population
Hitoshi Kawasuji, Yoshitomo Morinaga, Hideki Tani, Yumiko Saga, Makito Kaneda, Yushi Murai, Akitoshi Ueno, Yuki Miyajima, Yasutaka Fukui, Kentaro Nagaoka, Chikako Ono, Yoshiharu Matsuura, Hideki Niimi, Yoshihiro Yamamoto
medRxiv 2022.02.23.22271433; doi: https://doi.org/10.1101/2022.02.23.22271433

Bibliometric study of preclinical, clinical, and public health systematic reviews and meta-analyses in Ethiopia: systematically mapping publication outputs, authors collaboration networks, trending research topics, and influential articles
Tesfa Dejenie Habtewold, Nigussie Tadesse Sharew, Aklilu Endalamaw, Henok Mulugeta, Getenet Dessie, Nigus Gebremedhin Asefa, Getachew Mulu Kassa, Wubet Alebachew Bayih, Mulugeta Molla Birhanu, Andreas A. Teferra, Abera Kenay Tura, Balewgize Sileshi Tegegne, Sisay Mulugeta Alemu
medRxiv 2022.02.24.22271416; doi: https://doi.org/10.1101/2022.02.24.22271416

The impact of COVID passport mandates on the number of cases of and hospitalizations with COVID-19 in the UK: a difference-in-differences analysis
Kim López-Güell, Albert Prats-Uribe, Martí Catalá, Clara Prats, Jotun Hein, DANIEL PRIETO-ALHAMBRA
medRxiv 2022.02.24.22271325; doi: https://doi.org/10.1101/2022.02.24.22271325

Dynamics of the Delta and Omicron variants of SARS-CoV-2 in the United States: the battle of supremacy in the presence of vaccination, mask usage and antiviral treatment
Calistus N. Ngonghala, Hemaho B. Taboe, Abba B. Gumel
medRxiv 2022.02.23.22271394; doi: https://doi.org/10.1101/2022.02.23.22271394

When mistrust in the government and scientists reinforce social inequalities in vaccination against Covid-19
Nathalie Bajos, Alexis Spire, Léna Silberzan, Antoine Sireyjol, Florence Jusot, Laurence Meyer, Jeanna-Eve Franck, Josiane Warszawski, the EpiCov study group
medRxiv 2022.02.23.22271397; doi: https://doi.org/10.1101/2022.02.23.22271397

Estimating the impact of implementation and timing of COVID-19 vaccination programme in Brazil: a counterfactual analysis
Leonardo Souto Ferreira, Flavia Maria Darcie Marquitti, Rafael Lopes Paixão da Silva, Marcelo Eduardo Borges, Marcelo Ferreira da Costa Gomes, Oswaldo Gonçruz Cruz, Roberto André Kraenkel, Renato Mendes Coutinho, Paulo Inácio Prado, Leonardo Soares Bastos
medRxiv 2021.12.24.21268384; doi: https://doi.org/10.1101/2021.12.24.21268384

SARS-CoV-2 seroprevalence, vaccination, and hesitancy in agricultural workers in Guatemala
Diva M. Calvimontes, Lyndsay Krisher, Alex Cruz-Aguilar, Daniel Pilloni-Alessio, Luis E. Crisostomo-Cal, Edgar A. Castañeda-Sosa, Jaime Butler-Dawson, Daniel Olson, Lee S. Newman, Edwin J. Asturias
medRxiv 2022.02.22.22270907; doi: https://doi.org/10.1101/2022.02.22.22270907

An inactivated SARS-CoV-2 vaccine is safe and induces humoral and cellular immunity against virus variants in healthy children and adolescents in Chile
Jorge A Soto, Felipe Melo-González, Cristián Gutierrez-Vera, Bárbara M Schultz, Roslye V Berríos-Rojas, Daniela Rivera-Pérez, Alejandro Piña-Iturbe, Guillermo Hoppe-Elsholz, Luisa F Duarte, Yaneisi Vázquez, Daniela Moreno-Tapia, Mariana Ríos, Pablo A Palacios, Richard Garcia-Betancourt, Álvaro Santibañez, Constanza Mendez, Benjamín Diethelm-Varela, Patricio Astudillo, Mario Calvo, Antonio Cárdenas, Marcela González, Macarena Goldsack, Valentina Gutiérrez, Marcela Potin, Andrea Schilling, Lorena I Tapia, Loreto Twele, Rodolfo Villena, Alba Grifoni, Alessandro Sette, Daniela Weiskopf, Rodrigo A Fasce, Jorge Fernández, Judith Mora, Eugenio Ramírez, Aracelly Gaete-Argel, Mónica Acevedo, Fernando Valiente-Echeverría, Ricardo Soto-Rifo, Angello Retamal-Díaz, Nathalia Muñoz-Jofré, PedCoronaVac03CL Study Group, Xing Meng, Qianqian Xin, Eduardo Alarcón-Bustamante, José V González-Aramundiz, Nicole Le Corre, María Javiera Álvarez, Pablo A González, Katia Abarca, Cecilia Perret, Leandro J Carreño, Alexis M Kalergis, Susan M Bueno
medRxiv 2022.02.15.22270973; doi: https://doi.org/10.1101/2022.02.15.22270973

Community-based Case Studies of Vaccine Hesitancy and the COVID-19 Response in South Africa; The VaxScenes Study
Charles Shey Wiysonge, Nancy Coulson, Nirvana Pillay, Sara Cooper, Candice Groenewald, Zaynab Essack, Saahier Parker, Gregory Houston, Jane Simmonds, Anelisa Jaca, Muyunda Mutemwa, Patrick DMC Katoto, Heidi van Rooyen
medRxiv 2022.02.21.22271272; doi: https://doi.org/10.1101/2022.02.21.22271272

Anti-SARS-CoV-2 IgG antibodies after recovery from COVID-19 or vaccination in Libyan population: comparison of four vaccines
Fawzi Ebrahim, Salah Tabal, Yosra Lamami, Inas M Alhudiri, Salah Edin El Meshri, Samira M Al Dwigen, Ramadan Arfa, Asma Alboeshi, Hafsa A. Alemam, Fauzia Abuhtna, Rabeeah Altrhouni, Mohamed B Milad, Nada A Elgriw, Mahmoud A Ruaua, Zakarya Abusrewil, Warda Harroush, Mwada Jallul, Fouziyah S Ali, Farag Eltaeb, Adam Elzaghied
medRxiv 2022.02.18.22271130; doi: https://doi.org/10.1101/2022.02.18.22271130

Wellcome Open Research [to 26 Feb 2022]
https://wellcomeopenresearch.org/browse/articles
[Accessed 26 Feb 2022]

Wellcome Open Research provides all Wellcome researchers with a place to rapidly publish any results they think are worth sharing. All articles benefit from rapid publication, transparent peer review and editorial guidance on making all source data openly available.

Research Article metrics
Revised
Revealing the extent of the first wave of the COVID-19 pandemic in Kenya based on serological and PCR-test data [version 2; peer review: 1 approved, 1 approved with reservations]
John Ojal, Samuel P. C. Brand, Vincent Were, Emelda A. Okiro, Ivy K. Kombe, Caroline Mburu, Rabia Aziza, Morris Ogero, Ambrose Agweyu, George M. Warimwe, Sophie Uyoga, Ifedayo M. O. Adetifa, J. Anthony G. Scott, Edward Otieno, Lynette I. Ochola-Oyier, Charles N. Agoti, Kadondi Kasera, Patrick Amoth, Mercy Mwangangi, Rashid Aman, Wangari Ng’ang’a, Benjamin Tsofa, Philip Bejon, Edwine Barasa, Matt J. Keeling, D. James Nokes
Peer Reviewers Mark Kimathi; Amy Wesolowski
Funders
Wellcome Trust
National Institute for Health Research
Medical Research Council
Foreign, Commonwealth and Development Office
LATEST VERSION PUBLISHED 25 Feb 2022

Research Article metrics
Revised
Individual-level variations in malaria susceptibility and acquisition of clinical protection [version 3; peer review: 1 approved, 1 approved with reservations]
John Joseph Valletta, John W.G. Addy, Adam J. Reid, Francis M. Ndungu, Yaw Bediako, Jedida Mwacharo, Khadija Said, Jennifer Musyoki, Joyce Mwongeli Ngoi, Joshua Wambua, Edward Otieno, Matt Berriman, Philip Bejon, Kevin Marsh, Jean Langhorne, Chris I. Newbold, Mario Recker
Peer Reviewers Lucy C. Okell; Wendy Prudhomme-O’Meara and Christine Markwalter
Funders
Wellcome Trust
Cancer Research UK
Medical Research Council
Crick Africa Network
LATEST VERSION PUBLISHED 25 Feb 2022

Think Tanks

Posted on by

Think Tanks
 
 
Brookings
http://www.brookings.edu/
Accessed 26 Feb 2022
Upcoming Event
Public health in Africa: Ensuring equal access and self-sufficiency
Feb 28 9:30 AM – 11:00 AM EST
Online Only
 
 
Health Care Policy
5 building blocks to help achieve greater health equity
Stuart M. Butler and Nehath Sheriff
Tuesday, February 22, 2022
 
 
Center for Global Development [to 26 Feb 2022]
https://www.cgdev.org/
Accessed 26 Feb 2022
Operationalizing the African Medicines Agency: The Strategic Design of a Regional Platform for Medicines Regulation
Event 2/24/22
As of November 5, 2021, the African Union signed into force its second specialized health agency: the African Medicines Agency (AMA). More than two years after its introduction, the AMA treaty has now been ratified by 17 African Union member countries – two more than was required – and has been signed by many more, making it the latest regional partnership to strengthen capacity for medicines regulation and facilitate regulatory harmonization across the African continent in order to improve access to safe, effective, and quality-assured medicines. With high-level support secured, attention now must shift to strategic questions of how to operationalize the AMA and set it up for success.

February 16, 2022
Social Protection in the COVID-19 Pandemic: Lessons from South Africa
South Africa responded to the stresses of the COVID-19 pandemic and lockdown using a combination of existing social protection programmes, unemployment insurance, and additional measures to support those most affected. This paper reviews policies and implementation with the objective of highlighting lessons for the global community, including on the use of digital mechanisms.
Lena Gronbach , Jeremy Seekings and Vayda Megannon
 
 
Chatham House [to 26 Feb 2022]
https://www.chathamhouse.org/
Accessed 26 Feb 2022
Explainer The next pandemic – when could it be?
How, when, and where could a new pandemic occur, what measures might prevent such an event, and is the world well-prepared if it does happen?
23 February 2022

 
 

CSIS
https://www.csis.org/
Accessed 26 Feb 2022
Upcoming Event
Overcoming Gender-Related Barriers to Immunization Services
March 8, 2022

 
 
Kaiser Family Foundation
https://www.kff.org/search/?post_type=press-release
Accessed 26 Feb 2022
[No new digest content identified]
 
 
Rand [to 26 Feb 2022]
https://www.rand.org/pubs.html
Reports, Selected Journal Articles
Report
Incorporating Complementary and Integrative Health Providers in the Public Health Pandemic Response: Lessons from COVID-19 and Recommendations for the Future from a Multidisciplinary Expert Panel
Complementary and integrative health providers have been an underutilized public health asset in the response to the COVID-19 pandemic. This report seeks to inform how they can be better integrated into future responses to public health emergencies.
Feb 17, 2022
Ian D. Coulter, Margaret D. Whitley, Raheleh Khorsan, Patricia M. Herman

Report
COVID-19 Genomics UK (COG-UK) Consortium: Final Report
RAND Europe evaluated how the COVID-19 Genomics UK (COG-UK) Consortium contributed to the pandemic response in the United Kingdom and examined the role of pathogen genomics research and sequencing networks in pandemic response.
Feb 15, 2022
Sonja Marjanovic, Robert J. Romanelli, Gemma-Claire Ali, Brandi Leach, Margaretha Bonsu, Daniela Rodriguez-Rincon, Tom Ling